AAAAAA

   
Results: 1-3 |
Results: 3
New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives
Authors: Sonnet, P Dallemagne, P Guillon, J Enguehard, C Stiebing, S Tanguy, J Bureau, R Rault, S Auvray, P Moslemi, S Sourdaine, P Seralini, GE
Citation: P. Sonnet et al., New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives, BIO MED CH, 8(5), 2000, pp. 945-955
Synthesis of new 2-(aminomethyl)-4-phenylpyrrolo[1,2-a]quinoxalines and their preliminary in-vivo central dopamine antagonist activity evaluation in mice
Authors: Guillon, J Boulouard, M Lisowski, V Stiebing, S Lelong, V Dallemagne, P Rault, S
Citation: J. Guillon et al., Synthesis of new 2-(aminomethyl)-4-phenylpyrrolo[1,2-a]quinoxalines and their preliminary in-vivo central dopamine antagonist activity evaluation in mice, J PHARM PHA, 52(11), 2000, pp. 1369-1375
First synthesis of 1-phenyl-3-pyrrol-1-ylindan-2-carboxylic acid, a new scaffold of potential non-peptide endothelin receptor antagonists
Authors: Guillon, J Dallemagne, P Stiebing, S Bovy, PR Rault, S
Citation: J. Guillon et al., First synthesis of 1-phenyl-3-pyrrol-1-ylindan-2-carboxylic acid, a new scaffold of potential non-peptide endothelin receptor antagonists, SYNLETT, (8), 1999, pp. 1263-1264
Risultati: 1-3 |